1H-TETRAZOL İÇEREN YENİ 1,2,4-TRİAZOL TÜREVLERİNİN TASARIMI, SENTEZİ, ANTİMİKROBİYAL VE ANTİFUNGAL AKTİVİTELERİ

        Amaç: Antimikrobiyal ve antifungal ilaçlar dünyada en yaygın ilaç türlerindendir. Günümüzde mikroplara ve mantarlara karşı yeni ilacın üretilmesine ihtiyaç duyulur. Araştırmamızın amacı, 5-(1Н-tetrazol-1-il)-4Н-1,2,4-triazol-3-amin türevi yeni bileşiklerin sentezi ile sentez edilmiş bileşiklerin fizikokimyasal, antimikrobiyal ve antifungal özelliklerinin tespit edilmesidir.        Gereç ve Yöntem: 5-(1Н-tetrazol-1-ilmetil)-4Н-1,2,4-triazol-3-il-1-(alkil-, aril-)-metanim, 5-(1H-tetrazol-1-ilmetil)-4H-1,2,4-triazol-3-amin’in sirke asidinde aldehitler ile etkileşimi sonucunda sentez edilmiştir. Bir sonraki aşamada indirgen olarak sodyum borohidrür kullanıldığı için ikili bağ yeniden kurulabilmiştir. Sentez edilmiş bileşiklerin yapıları, kızılaltı, nükleer manyetik rezonans ve kütle spektroskopisi ile doğrulanır. Sentez edilmiş bileşikler mikrop ve mantarlara karşı aktivite konusunda serili dilüsyon metodu ile denetlenmiştir.         Sonuç ve Tartışma: Sentetik araştırmaların sonucunda 22 bileşikten oluşan yeni seri elde edilmiştir. 5-(1Н-tetrazol-1-ilmetil)-4Н-1,2,4-triazol-3-il-1-(5-nitrofuran-2-il)metanimin en iyi antimikrobiyal ve antifungal etkisine sahip olup Staphylococcus aureus (12,5/25 mg/ml), Escherichia coli (50/100 mg/ml), Pseudomonas aeruginosa (100/200 mg/ml), Candida albicans (50/50 mg/ml) için karşılaştırmalı ilacı geçtiğini tespit edilmiştir.

DESIGN, SYNTHESIS, ANTIMICROBIAL AND ANTIFUNGAL ACTIVITIES OF NEW 1,2,4-TRIAZOLE DERIVATIVES CONTAINING 1H-TETRAZOLE MOIETY

Objective: Antimicrobials and antifungals are the most acquired drugs in the world. Today, it becomes necessary to create new drugs with antimicrobial and antifungal effect. The purpose of our research is the synthesis of new series of 5-(1Н-tetrazole-1-yl)-4H-1,2,4-triazole-3-amine, the establishment of physical-chemical, antimicrobial and antifungal properties for all synthesized compounds. Materials and Methods: 5-(1Н-tetrazole-1-yl-methyl)-4H-1,2,4-triazole-3-yl-1-(alkyl-, aryl-)-methanimines were synthesized by reacting of 5-(1H-tetrazole-1-yl-methyl)-4H-1,2,4-triazole-3-amine with aldehydes in acetic acid. Then, sodium borohydride was selected as a reducing agent, which allowed for the restoration of the double bond. The structures of synthesized compounds were confirmed by IR, 1H NMR and mass spectra. The synthesized compounds were evaluated for antimicrobial and antifungal activity by "serial dilutions" method. Result and Discussion: During the synthetic studies the new series of 22 compounds were obtained. The 5-(1Н-tetrazole-1-yl-methyl)-4H-1,2,4-triazole-3-yl-1-(5-nitrofuran-2-yl)methanimine was observed to be most possessing good antimicrobial and antifungal and has exceeded the reference standard for Staphylococcus aureus (12,5/25 mg/ml), Escherichia coli (50/100 mg/ml), Pseudomonas Aeruginosa (100/200 mg/ml), Candida albicans (50/50 mg/ml).

___

  • 1. Sehrawat, R., Maithani, M., Singh,R. (2010). Regulatory Aspects in Development of Stability-Indicating Methods: A Review. Chromatographia, 72 (1/2), 1–6.
  • 2. Blessy, M, Ruchi, D.P., Prajesh, N.Pr., Agrawal, Y.K. (2014). Development of forced degradation and stability indicating studies of drugs-A review. Journal of Pharmaceutical Analysis; 4(3), 159–165.
  • 3. Klick, S., Muijselaar, P.G., Waterval, J., Eichinger, Th., Korn, C., Gerding, Th.K., Debets, Al.J., Van de Griend, C.S., Van den Beld, C., Somsen, G.W. and De Jong, G.J. (2005). Stress Testing of Drug Substances and Drug Products. Pharmaceutical Technology, FEBRUARY; 48–66.
  • 4. Chakravarthy, V.A., Sailaja, B.B.V., Kumar, A.P. (2015). Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enrofloxacin and Its Degradation Products in Tablet Dosage Forms. Journal of Analytical Methods in Chemistry, 2015, 1 – 11.
  • 5. Ahirrao, V.K., Patil, C.S., Bembalkar, S.R., Katariya, M.V., Sonnekar, V.S., Marathe, R.P., Nawale,R. B.,Pawar, R. P.(2012). Stress degradation studies of dronedarone in pharmaceutical dosage form by a validated stability-indicating LC method. Journal of the Chilean Chemical Society, 57(3); 1272 – 1276.
  • 6. Patel, J. K., Patel, N. K. (2014). Stability-Indicating RP-HPLC Method for the Determination of Ambrisentan and Tadalafil in Pharmaceutical Dosage Form. Scientia Pharmaceutica, 82, 749–763.
  • 7. Parchenko, V. V., Panasenko, O. I., Knysh, E. G., Vasyuk S. O., Tarkhanova, O. O. (2009). Working out of methods quantitative determination piperidiniy 2-[5-(furan-2-il)-4-phenil-1,2,4-triazol-3-ilthio]acetate in the substance. Ukrainskyi biofarmatsevtychnyi zhurnal, 4, 44–45.
  • 8. Parchenko, V.V., Panasenko, O.I., Knysh, E.G., Vasiuk, S.O., Tarkhanova, O. O. (2009). Qualitative and quantitative determination of the Piperidinium 2-((5-(furan-2-yl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)acetate 1% and 2,5% solutions. Zaporozhye medical journal, 3, 111–112.
  • 9. Varynskyi, B. O., Parchenko, V.V., Kaplaushenko, А. G. (2017). Development and validation of HPLC-DAD method of determination piperidinium 2-((5-(furan-2-yl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)acetate in 1 % solution, Zaporozhye medical journal, 19 (6), 827-832.
  • 10. Parchenko, V. (2006). Synthesis, physicochemical and biological properties of derivatives of 1,2,4-triazoles-3-thione containing core furan. Candidate of Pharm Scithesis, Zaporozhye State Medical University, Zaporozhye, 208 p.
  • 11. Parchenko, V. (2014). Synthesis, transformation, physico-chemical and biological properties in a number of 5-furyl-substituted 1,2,4-triazole-3-thiones. Dr. Pharmacist Sciences thesis, Zaporozhye State Medical University, Zaporozhye, 460 p.
  • 12. Tietze, L.F., Eicher, Th. (1991). Reaktionen und Synthesen im organisch‐chemischen Praktikum und Forschungs laboratorium. 2. Aufl., Georg Thieme Verlag, Stuttgart – NewYork. DM 68, 672 S.
Ankara Üniversitesi Eczacılık Fakültesi Dergisi-Cover
  • ISSN: 1015-3918
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 2016
  • Yayıncı: Ankara Üniversitesi Eczacılık Fakültesi
Sayıdaki Diğer Makaleler

ALZHEİMER HASTALIĞININ GELİŞİMİNDE BİYOLOJİK AJANLARIN OLASI ETKİLERİ

Ayça ADALI, Anıl YİRÜN, Belma KOÇER-GÜMÜŞEL, Pınar ERKEKOĞLU

YENİ TAKRİN VE HESPERETİN ANALOGLARI: ALZHEİMER HASTALIĞINDA POTANSİYEL ASETİLKOLİN ESTERAZ İNHİBİTÖRLERİNİN AYDINLATILMASI İÇİN TASARIM, MOLEKÜLER DOKİNG VE İN SİLİKO ADME ÇALIŞMALARI

Naresh KONDAPALLI, Kanna SRUTHI

KENEVİR VE SAĞLIK ALANINDA KULLANIMI

Ufuk KOCA ÇALIŞKAN, Selda YILDIRIM

OKÜLER UYGULAMA İÇİN VORİKONAZOL YÜKLÜ İN SİTU JELLERİN FORMÜLASYONU VE DETAYLI KARAKTERİZASYONU

Neslihan ÜSTÜNDAĞ OKUR, Vildan YOZGATLI, Zeynep ŞENYİĞİT

PSEUDOMONAS AERUGINOSA İLE ENFEKTE EDİLMİŞ CİVCİVLERİN KARACİĞERİNE POTASYUM 2-((4-AMİNO-5-(MORFOLİNOMETİL)-4H-1,2,4-TRİAZOL-3- İL)TİYO)ASETAT (PKR-173) BİLEŞİĞİNİN DÜZELTİCİ ETKİSİNİN HİSTOLOJİK OLARAK ARAŞTIRILMASI

Yevgenia VASHCHYK, Roman SHCHERBYNA, Volodymyr PARCHENKO, İnna BUSHUEVA, Bogdan GUTYJ, Hanna FOTINA, Tatiana FOTINA, Yuriy STRONSKYI

1H-TETRAZOL İÇEREN YENİ 1,2,4-TRİAZOL TÜREVLERİNİN TASARIMI, SENTEZİ, ANTİMİKROBİYAL VE ANTİFUNGAL AKTİVİTELERİ

Yuliia FROLOVA, Andriy KAPLAUSHENKO, Nataliya NAGORNAYA

YEŞİL ÇAY VE SİYAH ÇAY EKSTRELERİNDEKİ GALLİK ASİT, EGCG İÇERİĞİ VE ANTİRADİKAL AKTİVİTESİNİN DEĞERLENDİRİLMESİ

Asli CAN AGCA, Kadir BATÇIOĞLU, Engin ŞARER

AMELANCHIER MEDIK. (ROSACEAE) CİNSİNİN FARMASÖTİK BOTANİK AÇISINDAN ÖNEMİ

Muhammed Mesud HÜRKUL, Ayşegül KÖROĞLU

YENİ 3-(ALKİLTİYO)-5-(TİYOFEN-2-İLMETİL)-1,2,4-TRİAZOL-4-AMİNLERİN MİKRODALGA SENTEZİ

Andrey SAFONOV

TÜRKİYE'DE DOĞAL OLARAK YETİŞEN VE AKTARLARDA SATILAN SUMAK (RHUS CORIARIA L.) MEYVELERİNİN YAĞ ASİDİ KOMPOZİSYONLARININ KİMYASAL KARAKTERİZASYONU VE ANTİMİKROBİYAL AKTİVİTESİ

Gülderen YILMAZ, Gulnur EKŞİ, Betül DEMİRCİ, Fatih DEMİRCİ